Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E, Giordano L, Torrisi R, De Sanctis R, Masci G, Losurdo A, Zuradelli M, Tinterri C, Gatzemeier W, Testori A, Alloisio M, De Rose F, Fernandes B, Santoro A. Agostinetto E, et al. Among authors: torrisi r. Clin Breast Cancer. 2020 Aug;20(4):e481-e489. doi: 10.1016/j.clbc.2020.02.011. Epub 2020 Mar 6. Clin Breast Cancer. 2020. PMID: 32279915
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, Gelber RD, Curigliano G, Torrisi R, Luini A, Intra M, Galimberti V, Renne G, Nolè F, Peruzzotti G, Goldhirsch A. Colleoni M, et al. Among authors: torrisi r. Clin Cancer Res. 2004 Oct 1;10(19):6622-8. doi: 10.1158/1078-0432.CCR-04-0380. Clin Cancer Res. 2004. PMID: 15475452 Free article.
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease.
Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Orlando L, Ghisini R, Viale G, Pruneri G, Veronesi P, Luini A, Intra M, Cardillo A, Torrisi R, Rocca A, Goldhirsch A. Colleoni M, et al. Among authors: torrisi r. Ann Oncol. 2006 Oct;17(10):1497-503. doi: 10.1093/annonc/mdl145. Epub 2006 Jun 23. Ann Oncol. 2006. PMID: 16798834 Free article.
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Torrisi R, Balduzzi A, Ghisini R, Rocca A, Bottiglieri L, Giovanardi F, Veronesi P, Luini A, Orlando L, Viale G, Goldhirsch A, Colleoni M. Torrisi R, et al. Cancer Chemother Pharmacol. 2008 Sep;62(4):667-72. doi: 10.1007/s00280-007-0652-z. Epub 2007 Dec 7. Cancer Chemother Pharmacol. 2008. PMID: 18064460 Clinical Trial.
151 results